Article ID Journal Published Year Pages File Type
8525464 Biomedicine & Pharmacotherapy 2018 7 Pages PDF
Abstract
Our findings reveal that sanguinarine exhibits antitumor effects in epithelial ovarian cancer cells possible via regulating CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway. Sanguinarine may serve as a potential therapeutic reagent for epithelial ovarian cancer.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, , , , , ,